These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 19807918)

  • 21. [Nilotinib in patients with chronic myeloid leukemia without response to imatinib].
    Báez-de la Fuente E; Arellano-Severiano B
    Rev Med Inst Mex Seguro Soc; 2014; 52(3):330-3. PubMed ID: 24878095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pregnancy in Patients With Chronic Myeloid Leukemia.
    Berman E
    J Natl Compr Canc Netw; 2018 May; 16(5S):660-662. PubMed ID: 29784750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance.
    Kantarjian HM; Giles F; Gattermann N; Bhalla K; Alimena G; Palandri F; Ossenkoppele GJ; Nicolini FE; O'Brien SG; Litzow M; Bhatia R; Cervantes F; Haque A; Shou Y; Resta DJ; Weitzman A; Hochhaus A; le Coutre P
    Blood; 2007 Nov; 110(10):3540-6. PubMed ID: 17715389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful pregnancy and delivery in a patient with chronic myelogenous leukemia (CML), and management of CML with leukapheresis during pregnancy: a case report and review of the literature.
    Ali R; Ozkalemkaş F; Ozkocaman V; Ozçelik T; Ozan U; Kimya Y; Tunali A
    Jpn J Clin Oncol; 2004 Apr; 34(4):215-7. PubMed ID: 15121759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pregnancy in patients with chronic myeloid leukemia treated with imatinib.
    Yilmaz M; Demirhan O; Kuçukosmanoglu E; Pehlivan M; Okan V; Balat O; Pehlivan S
    Leuk Lymphoma; 2007 Dec; 48(12):2454-6. PubMed ID: 18067024
    [No Abstract]   [Full Text] [Related]  

  • 26. Breastfeeding in a patient with chronic myeloid leukemia during tyrosine kinase inhibitor therapy.
    Terao R; Nii M; Asai H; Nohara F; Okamoto T; Nagaya K; Azuma H
    J Oncol Pharm Pract; 2021 Apr; 27(3):756-760. PubMed ID: 32787559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pregnancy among patients with chronic myeloid leukemia treated with imatinib.
    Ault P; Kantarjian H; O'Brien S; Faderl S; Beran M; Rios MB; Koller C; Giles F; Keating M; Talpaz M; Cortes J
    J Clin Oncol; 2006 Mar; 24(7):1204-8. PubMed ID: 16446320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful Pregnancy and Delivery in a Patient with Chronic Myeloid Leukemia while on Dasatinib Therapy.
    Conchon M; Sanabani SS; Serpa M; Novaes MM; Nardinelli L; Ferreira PB; Dorliac-Llacer PE; Bendit I
    Adv Hematol; 2010; 2010():136252. PubMed ID: 20224653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful outcome of pregnancy in a patient with chronic myelogenous leukemia exposed to imatinib during the first trimester.
    Suppiah R; Kalaycio M
    Leuk Lymphoma; 2006 Jun; 47(6):1149-50. PubMed ID: 16840209
    [No Abstract]   [Full Text] [Related]  

  • 30. Pregnancy outcomes in patients with chronic myeloid leukemia treated with imatinib mesylate: short report from a developing country.
    Iqbal J; Ali Z; Khan AU; Aziz Z
    Leuk Lymphoma; 2014 Sep; 55(9):2109-13. PubMed ID: 24237577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nilotinib is superior to imatinib as first-line therapy of chronic myeloid leukemia: the ENESTnd study.
    Giles FJ; Rosti G; Beris P; Clark RE; le Coutre P; Mahon FX; Steegmann JL; Valent P; Saglio G
    Expert Rev Hematol; 2010 Dec; 3(6):665-73. PubMed ID: 21091142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two successful pregnancies in a chronic myeloid leukemia patient treated with imatinib.
    Garderet L; Santacruz R; Barbu V; van den Akker J; Carbonne B; Gorin NC
    Haematologica; 2007 Jan; 92(1):e9-10. PubMed ID: 17405743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Normal outcome of pregnancy in chronic myeloid leukemia treated with interferon-alpha in 1st trimester: report of 3 cases and review of the literature.
    Mubarak AA; Kakil IR; Awidi A; Al-Homsi U; Fawzi Z; Kelta M; Al-Hassan A
    Am J Hematol; 2002 Feb; 69(2):115-8. PubMed ID: 11835347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expanding Nilotinib Access in Clinical Trials (ENACT): an open-label, multicenter study of oral nilotinib in adult patients with imatinib-resistant or imatinib-intolerant Philadelphia chromosome-positive chronic myeloid leukemia in the chronic phase.
    Nicolini FE; Turkina A; Shen ZX; Gallagher N; Jootar S; Powell BL; De Souza C; Zheng M; Szczudlo T; le Coutre P
    Cancer; 2012 Jan; 118(1):118-26. PubMed ID: 21732337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving frontline treatment for chronic myeloid leukemia: emerging evidence for use of nilotinib and dasatinib.
    Erba HP; Pham DC; Zaiden R; Vu H; Tai S
    Clin Adv Hematol Oncol; 2011 Oct; 9(10):734-45. PubMed ID: 22252576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response to treatment in women with chronic myeloid leukemia during pregnancy and after delivery.
    Klamová H; Marková M; Moravcová J; Sisková M; Cetkovský P; Machová Poláková K
    Leuk Res; 2009 Nov; 33(11):1567-9. PubMed ID: 19580997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nilotinib versus dasatinib as second-line therapy in patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase who are resistant or intolerant to imatinib: a cost-effectiveness analysis based on real-world data.
    Li N; Yang X; Fan L; Totev T; Guerin A; Chen L; Bhattacharyya S; Joseph G
    J Med Econ; 2017 Apr; 20(4):328-336. PubMed ID: 27841717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pregnancy outcome of two patients treated with imatinib.
    Prabhash K; Sastry PS; Biswas G; Bakshi A; Prasad N; Menon H; Parikh PM
    Ann Oncol; 2005 Dec; 16(12):1983-4. PubMed ID: 16100234
    [No Abstract]   [Full Text] [Related]  

  • 39. Persistence of molecular remission throughout pregnancy in CML after imatinib.
    Sorà F; De Matteis S; Bajer J; D'alò F; Leone G; Sica S
    Leuk Res; 2009 Jun; 33(6):e6-7. PubMed ID: 18937976
    [No Abstract]   [Full Text] [Related]  

  • 40. Impact of baseline BCR-ABL mutations on response to nilotinib in patients with chronic myeloid leukemia in chronic phase.
    Hughes T; Saglio G; Branford S; Soverini S; Kim DW; Müller MC; Martinelli G; Cortes J; Beppu L; Gottardi E; Kim D; Erben P; Shou Y; Haque A; Gallagher N; Radich J; Hochhaus A
    J Clin Oncol; 2009 Sep; 27(25):4204-10. PubMed ID: 19652056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.